Oncology Medical News about acute myeloid leukemia

Your Unread Messages

See All

Hello, Mary O'connor
Manage E-mail | Logout

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. Recommendations on the use of 18F-FDG PET in oncology

3. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials

4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer

5. Sentinel node biopsy is important in mastectomy for ductal carcinoma in situ

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Mitoxantrone and etoposide in patients with newly diagnosed acute myeloid leukemia with persistent leukemia after a course of therapy with cytarabine and idarubicin
Leukemia and Lymphoma, 11/06/09

McHayleh W et al. – A lower CR rate was associated with unfavorable risk status at diagnosis and higher percent blasts. The data suggest that the combination of etoposide and mitoxantrone is an effective second–course therapy in patients with newly diagnosed AML.

<< Previous
Epidermal growth factor receptor expression escapes androgen...

Next >>
Genistein reverses hypermethylation and induces active histone...

Acute pulmonary failure during remission induction chemotherapy in adults with acute myeloid leukemia or high-risk myelodysplastic syndrome
Cancer, 10/29/09 Relevance Score: 82%

Daunorubicin Versus Mitoxantrone Versus Idarubicin as Induction and Consolidation Chemotherapy for Adults With Acute Myeloid Leukemia: The EORTC and GIMEMA Groups Study AML-10
Journal of Clinical Oncology, 10/23/09 Relevance Score: 82%

Acute myeloid leukemia with mutated NPM1: diagnosis, prognosis and therapeutic perspectives
Current Opinion in Oncology, 10/14/09 Relevance Score: 82%

FLT3 inhibition as a targeted therapy for acute myeloid leukemia
Current Opinion in Oncology, 10/14/09 Relevance Score: 82%

Allogeneic hematopoietic cell transplantation after conditioning with 131I-anti-CD45 antibody plus fludarabine and low-dose total body irradiation for elderly patients with advanced acute myeloid leukemia or high-risk myelodysplastic syndrome
Blood, 10/02/09 Relevance Score: 82%